Mirae Asset Global Etfs Holdings Ltd. Syndax Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 53,748 shares of SNDX stock, worth $705,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,748
Previous 51,937
3.49%
Holding current value
$705,173
Previous $999,000
28.93%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$112 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$104 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$78.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$69.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$64.1 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $742M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...